The current study focused on analyzing the spectrum of reported BEST1 mutations and resulting phenotypes, as well as summarizing the genetic and clinical data of diagnosed Israeli patients with Best disease in order to determine the prevalence of the disease. This evidence concerns the gene BEST1 and Best vitelliform macular dystrophy.